Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Healthcare Drug Manufacturers - Major Cannabis
Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Aphria Inc.
Bullboard Posts
User Avatar Image
(93)
•••
Comment by Vinny57on Apr 16, 2018 3:50pm
100 Views
Post# 27893174

RE:RE:RE:RE:RE:$13 by end of day

RE:RE:RE:RE:RE:$13 by end of day
Trodzburger wrote: Dont listen to it. I’ve saw your posts. They are rational. This crowd doesn’t much care for rationale. Do what is best for you. If that is buying and quickly selling for a tidy profit, so be it. It’s like the blind leading the blind in here. Can’t be a true “Aphrian” with non working male parts unles you buy and hold 1 position for x years. 

15 by EOD. 5 stars

50 by summer 5 stars

2000000 by 2025 5.5 stars

complete and utter lunacy here

trodz


Did you just really say, "I'VE SAW your posts"?
"Dont" instead of Don't.
and, "Unles" instead of unless.
Plus another reference to male genitalia?
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities